APOBEC3B and neoplasm: In the third model, the impact of A3H-I is evident among early-arising clonal mutation spectrum in lung adenocarcinomas but it eventually becomes eclipsed by A3B overexpression at a later point in tumour development (continuous mutator plus activated (late) mutator model in Fig. 7c).